MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$105,433K
EPS
-$1.85
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Research and development
100,640
General and administrative
21,411
Total operating expenses
122,051
Loss from operations
-122,051
Interest income
16,630
Other income (expense), net
-12
Total other income, net
16,618
Net loss
-105,433
Basic EPS
-1.85
Diluted EPS
-1.85
Basic Average Shares
45,614,142
Diluted Average Shares
45,614,142
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Interest income$16,630K Net loss-$105,433K Total other income,net$16,618K Other income(expense), net-$12K Loss from operations-$122,051K Total operatingexpenses$122,051K Research and development$100,640K General andadministrative$21,411K

Oruka Therapeutics, Inc. (ORKA)

Oruka Therapeutics, Inc. (ORKA)